Evidence map›Paper›PMID 10445880›Full record

ArticleRNA (New York, N.Y.)1999

Overexpression of truncated Nmd3p inhibits protein synthesis in yeast.

J P Belk, F He, A Jacobson

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

J P BelkDepartment of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester 01655-0122, USA.
F He
A Jacobson

Funding

Messenger RNA Metabolism in YeastR37GM027757 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JACOBSON, ALLAN S · 2005 to 2014
$6.3M
MESSENGER RNA METABOLISM IN YEASTR01GM027757 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI JACOBSON, ALLAN S · 1985 to 2016
$3.8M
NIGMS NIH HHS GM27757NIGMS NIH HHS R01 GM027757
6 · The paper itself

Abstract

The yeast NMD3 gene was identified in a two-hybrid screen using the nonsense-mediated mRNA decay factor, Upf1p, as bait. NMD3 was shown to encode an essential, highly conserved protein that associated principally with free 60S ribosomal subunits. Overexpression of a truncated form of Nmd3p, lacking 100 C-terminal amino acids and most of its Upf1p-interacting domain, had dominant-negative effects on both cell growth and protein synthesis and promoted the formation of polyribosome half-mers. These effects were eliminated by truncation of an additional 100 amino acids from Nmd3p. Overexpression of the nmd3delta100 allele also led to increased synthesis and destabilization of some ribosomal protein mRNAs, and increased synthesis and altered processing of 35S pre-rRNA. Our data suggest that Nmd3p has a role in the formation, function, or maintenance of the 60S ribosomal subunit and may provide a link for Upf1p to 80S monosomes.

Indexed as

RNA-Binding ProteinsSaccharomyces cerevisiae ProteinsAmino Acid SequenceBlotting, NorthernCell DivisionCloning, MolecularFungal ProteinsGalactoseGene Expression Regulation, FungalGenes, DominantModels, GeneticMolecular Sequence DataPolyribosomesProtein BiosynthesisProtein Synthesis InhibitorsRNA HelicasesFungal ProteinsGalactoseNAM7 protein, S cerevisiaeNMD3 protein, S cerevisiaeProtein Synthesis InhibitorsRNA-Binding ProteinsRNA HelicasesRNA, MessengerRNA, RibosomalSaccharomyces cerevisiae Proteins

Identifiers

PMID10445880
PMCPMC1369829

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.